DIREcToRS AnD coRPoRATE AUDIToRS  (as of June 18, 2014) 1. Masafumi Nogimori Representative Director and Chairman 2. Yoshihiko Hatanaka Representative Director, President and CEO 3. Yoshiro Miyokawa Representative Director and Executive Vice President 4. Naoki Aikawa, M.D., Ph.D. Outside Director Outside Director 5. Yutaka Kase 6. Hironobu Yasuda Outside Director Astellas Pharma Inc.  _ Annual Report 2014 80 1969: Assistant in Surgery, School of Medicine, Keio University 1973: Research Fellow in Surgery, Harvard Medical School 1978: Chief Surgeon, Saiseikai Kanagawaken Hospital 1988: Associate Professor, Emergency & Critical Care  Medicine, School of Medicine, Keio University 1992: Professor, School of Medicine, (Emergency and Critical  Care), Keio University 1999: Director, Keio University Medical Media Center 2003: General Director, Keio University Hospital 2009: Professor Emeritus, Keio University (present post) 2009: Special advisor (Part-time), Social Welfare Organization  Tokyo Saiseikai Central Hospital (present post) 2011: Director of the Company (present post) 1970: Joined Nissho Iwai Corporation 2001: Executive Officer, Nissho Iwai Corporation 2003: Managing Executive Officer and Director,  Nissho Iwai Corporation 2004: Senior Managing Executive Officer and  Representative Director, Sojitz Corporation 2004: Executive Vice President and Representative  Director, Sojitz Corporation 2007: President and Representative Director, Sojitz  Corporation 2012: Chairman and Representative Director, Sojitz  Corporation (present post) 2013: Director of the Company (present post) 1978: Public Prosecutor, Tokyo District Public  Prosecutors Office 2004: Public Prosecutor, Tokyo High Public  Prosecutors Office 2005: Chief Appeals Judge (Director of Tokyo  Regional Tax Tribunal) 2009: Chief Prosecutor, Yamaguchi District Public  Prosecutors Office 2010: Public Prosecutor, Supreme Public Prosecutors Office 2010: Registered as an attorney-at-law (Dai-ichi Tokyo Bar Association) 2012: Partner, Seiryo Law Office (present post) 2013: Director of the Company (present post) 1975: Joined the Company 2003: Vice President of Business Process Reengineering of the Company 2005: Vice President of Post-Merger Integration Operation of the Company 2005: Corporate Executive and Vice President of Post-Merger  Integration Operation of the Company 2005: Corporate Executive and Vice President of Business  Innovation of the Company 2006: Corporate Executive and Vice President of Human  Resources, Corporate Administration Division of the  Company 2007: Corporate Executive and Vice President of Human  Resources of the Company 2008: Corporate Executive of the Company, Corporate  Administration (CAO) 2008: Senior Corporate Executive of the Company, Corporate Administration (CAO) 2011: Executive Vice President and Senior Corporate Executive  of the Company, Corporate Administration (CAO) 2013: Executive Vice President and Representative Director of the Company, Corporate Administration and  Compliance (CAO & CCO) (present post) 1980: Joined Fujisawa Pharmaceutical Co., Ltd. 2003: Director of Corporate Planning, Fujisawa  Pharmaceutical Co., Ltd. 2005: Vice President of Corporate Planning,  Corporate Strategy Division of the Company 2005: Corporate Executive and Vice President of  Corporate Planning, Corporate Strategy of the  Company 2006: Corporate Executive of the Company and  President & CEO, Astellas US LLC and  President & CEO, Astellas Pharma US, Inc. 2008: Senior Corporate Executive of the Company  and President & CEO, Astellas US LLC and  President & CEO, Astellas Pharma US, Inc. 2009: Senior Corporate Executive of the Company,  Corporate Strategy and Corporate Finance (CFO & CSTO) 2011: President & CEO and Representative Director of  the Company (present post) 1970: Joined Fujisawa Pharmaceutical Co., Ltd. 1997: Member of the Board, Fujisawa Pharmaceutical Co., Ltd. 1998: President, Fujisawa GmbH 2000: Resigned as Member of the Board, Fujisawa  Pharmaceutical Co., Ltd., Corporate Vice President,  Fujisawa Pharmaceutical Co., Ltd. 2001: Corporate Vice President, Associate Executive  Director of Ethical Pharmaceuticals and Director of  Pharmaceutical Planning, Fujisawa Pharmaceutical  Co., Ltd. 2001: Corporate Senior Vice President and Director of  Global Corporate Strategies Planning, Fujisawa  Pharmaceutical Co., Ltd. 2003: Member of the Board, Fujisawa Pharmaceutical Co., Ltd. 2004: Corporate Executive Vice President and Member of  the Board, Fujisawa Pharmaceutical Co., Ltd. 2005: Executive Vice President and Representative Director  of the Company 2006: President & CEO and Representative Director of the  Company 2011: Chairman and Representative Director of the  Company (present post) 2 7 3 4 5 6